Clarivate PLC (NYSE:CLVT) Receives $4.83 Average Price Target from Analysts

Shares of Clarivate PLC (NYSE:CLVTGet Free Report) have received a consensus recommendation of “Reduce” from the six research firms that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation and four have issued a hold recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $4.8333.

CLVT has been the topic of several research reports. Wolfe Research initiated coverage on Clarivate in a research report on Wednesday, September 3rd. They issued a “peer perform” rating on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Clarivate in a research report on Tuesday, October 14th. Finally, Jefferies Financial Group initiated coverage on Clarivate in a research report on Friday, July 18th. They issued a “hold” rating and a $4.50 target price on the stock.

View Our Latest Research Report on CLVT

Institutional Investors Weigh In On Clarivate

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Neuberger Berman Group LLC increased its holdings in shares of Clarivate by 2.4% in the first quarter. Neuberger Berman Group LLC now owns 108,980 shares of the company’s stock valued at $428,000 after purchasing an additional 2,520 shares during the last quarter. Cetera Investment Advisers increased its holdings in shares of Clarivate by 11.2% in the second quarter. Cetera Investment Advisers now owns 26,034 shares of the company’s stock valued at $112,000 after purchasing an additional 2,617 shares during the last quarter. California State Teachers Retirement System increased its holdings in shares of Clarivate by 0.9% in the second quarter. California State Teachers Retirement System now owns 303,147 shares of the company’s stock valued at $1,304,000 after purchasing an additional 2,788 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in shares of Clarivate by 7.6% in the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 40,253 shares of the company’s stock valued at $158,000 after purchasing an additional 2,858 shares during the last quarter. Finally, Millstone Evans Group LLC increased its holdings in shares of Clarivate by 156.6% in the first quarter. Millstone Evans Group LLC now owns 7,545 shares of the company’s stock valued at $30,000 after purchasing an additional 4,605 shares during the last quarter. Institutional investors and hedge funds own 85.72% of the company’s stock.

Clarivate Stock Performance

NYSE CLVT opened at $3.69 on Thursday. The company has a market cap of $2.48 billion, a PE ratio of -5.94 and a beta of 1.44. The stock’s 50 day simple moving average is $4.01 and its 200-day simple moving average is $4.08. Clarivate has a 1-year low of $3.04 and a 1-year high of $6.72. The company has a debt-to-equity ratio of 0.90, a current ratio of 0.91 and a quick ratio of 0.91.

Clarivate (NYSE:CLVTGet Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.18 earnings per share for the quarter, meeting the consensus estimate of $0.18. The business had revenue of $621.40 million for the quarter, compared to the consensus estimate of $587.17 million. Clarivate had a positive return on equity of 8.65% and a negative net margin of 17.33%.The business’s quarterly revenue was down 4.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.20 earnings per share. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. As a group, equities research analysts anticipate that Clarivate will post 0.63 EPS for the current fiscal year.

About Clarivate

(Get Free Report)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

Read More

Analyst Recommendations for Clarivate (NYSE:CLVT)

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.